Search

everythinglearnresearchcommunity

for

Search:↓

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

There is unequal access to gender-affirming surgeries in Canada, with a need for better coverage and specialized programs.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

The development of breeding tubercles in male zebrafish relies on a specific enzyme that processes hormones.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Severe and early hair loss may indicate a higher risk of heart disease.

Stopping finasteride can lead to lasting sexual and psychological issues.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

Severe hair loss may worsen with skin condition, suggesting treating the skin might help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Androgenetic alopecia may improve meibum quality in eyes.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

PCOS often causes acne, dark skin patches, excess hair, and hair loss, linked to hormone levels and obesity.

Newborn skin conditions like Epstein pearls and Mongolian spots are common and influenced by race, environment, and hormones.

Valproic acid is effective but often causes side effects like weight gain and hair loss, so personalized treatment is needed.

Exposure to plastics may increase the risk of irregular menstrual cycles and symptoms of hormone imbalance in teenage girls.

Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.